Tag: Pharmaceutical Science Impact Award

Prem Shankar Mishra | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Dr. Prem Shankar Mishra | Pharmaceutical Science | Best Researcher Award

Professor at Galgotias University, India

Dr. Prem Shankar Mishra is a distinguished academician and pharmaceutical scientist currently serving as Associate Professor and Head of the D.Pharm Programme at Galgotias University. With over a decade of experience in teaching, research, and academic administration, he has established himself as a result-oriented educator and innovative researcher in pharmaceutical sciences. His expertise spans drug design, heterocyclic synthesis, molecular docking, anticancer research, and analytical characterization techniques. Dr. Mishra has successfully guided undergraduate and diploma pharmacy students while contributing significantly to curriculum development, accreditation processes, and outcome-based education systems. He has published numerous research articles in reputed international journals and authored book chapters with global publishers. In addition to his academic contributions, he holds multiple granted Indian and international patents in the fields of pharmaceutical formulations, synthetic chemistry, and biomedical devices. His leadership roles in NAAC/NBA accreditation activities and conference organization reflect his administrative competence and commitment to quality education. Dr. Mishra integrates research innovation with academic excellence, promoting interdisciplinary collaboration and fostering a culture of scientific inquiry. His professional journey reflects dedication to advancing pharmaceutical education and impactful drug discovery research.

Professional Profile

Education

Dr. Prem Shankar Mishra possesses a strong and multidisciplinary academic foundation in pharmacy and law. He completed his Ph.D. in Pharmacy from VISTAS in 2021, focusing on the design, synthesis, and evaluation of 2-pyridone derivatives as potential anticancer agents. His doctoral research emphasized drug design, heterocyclic synthesis, molecular docking, and in-vitro anticancer evaluation under expert supervision from NIPER Kolkata leadership. He earned his Master of Pharmacy (M.Pharm) in Pharmaceutical Chemistry from The Tamil Nadu Dr. M.G.R. Medical University in 2010, building strong expertise in synthetic chemistry and analytical techniques. Earlier, he completed his Bachelor of Pharmacy (B.Pharm) from an institution affiliated with Uttar Pradesh Technical University in 2007. Expanding his interdisciplinary knowledge, he also obtained a Bachelor of Laws (LL.B.) degree from Chaudhary Charan Singh University in 2017. His educational background combines pharmaceutical sciences, research methodology, regulatory awareness, and legal understanding, enabling him to contribute effectively to academic leadership, patent development, and regulatory compliance in higher education and pharmaceutical research.

Professional Experience

Dr. Prem Shankar Mishra has more than ten years of comprehensive experience in teaching, research supervision, and academic administration. Since December 2017, he has been serving as Associate Professor in the Department of Pharmacy at Galgotias University, where he also holds the position of Head of the D.Pharm Programme. In this role, he oversees curriculum implementation, faculty coordination, accreditation processes, regulatory compliance with PCI, NAAC, and NBA standards, and academic planning aligned with outcome-based education under the Washington Accord framework. Prior to this, he worked as Assistant Professor at Meerut Institute of Engineering and Technology from 2010 to 2017, contributing to undergraduate and postgraduate pharmacy education. He also gained early teaching experience as a guest lecturer at Government Polytechnic College, Lakhimpur Kheri. Beyond classroom teaching, Dr. Mishra has organized international conferences, participated in faculty development programs, and served as an external examiner for pharmacy institutions. His professional journey reflects consistent academic growth, leadership in quality assurance initiatives, student mentorship, and active engagement in research-driven pharmaceutical education and institutional development.

Research Interests

Dr. Prem Shankar Mishra’s research interests are centered on pharmaceutical chemistry with a strong emphasis on anticancer drug discovery and development. His primary focus includes the design, synthesis, and characterization of heterocyclic compounds, particularly 2-pyridone and pyridazine derivatives, for potential therapeutic applications. He actively integrates in-silico molecular docking studies with wet-lab synthesis and biological evaluation to accelerate rational drug design. His expertise extends to cell culture-based assays such as MTT assays, flow cytometry (FACS), cell cycle analysis, and reactive oxygen species studies for evaluating cytotoxic effects. Dr. Mishra is also interested in green synthesis approaches, nano-formulations, transdermal delivery systems, and advanced analytical techniques including IR, NMR, HPLC, and UV spectroscopy. He has contributed to computational drug discovery, deep learning applications in site-specific drug delivery, and immunotherapy-based strategies targeting skin cancer. His interdisciplinary research approach bridges synthetic organic chemistry, computational modeling, pharmacological screening, and formulation science. Through funded proposals and patented innovations, he continues to explore novel bioactive molecules and advanced drug delivery systems aimed at improving therapeutic efficacy and safety.

Awards and Honors

Dr. Prem Shankar Mishra has received notable recognition for his academic and research contributions in pharmaceutical sciences. He has secured multiple granted Indian and international patents, including innovations in nanoemulgel formulations, pyridazine derivatives, antimicrobial devices, and transdermal drug delivery systems. His research initiatives have attracted funding support, including a grant from DRDO for organizing a national conference, reflecting institutional trust in his academic leadership. He has actively participated in national and international conferences, winning awards such as first prize in oral presentation during National Pharmacy Week. Dr. Mishra has completed several prestigious NPTEL-AICTE and AICTE-ATAL sponsored faculty development programs focusing on accreditation, patent creation, outcome-based education, and innovative pedagogy. His involvement as a core team member in NAAC/NBA accreditation processes highlights his commitment to maintaining academic quality standards. Additionally, he has served as an external examiner and evaluator for pharmacy institutions. These achievements demonstrate his dedication to academic excellence, research innovation, patent development, professional training, and continuous professional growth in pharmaceutical education and drug discovery research.

Conclusion

Dr. Prem Shankar Mishra exemplifies a balanced integration of academic excellence, innovative research, and effective leadership in pharmaceutical sciences. With strong qualifications in pharmacy and law, extensive teaching experience, and active engagement in drug discovery research, he has made meaningful contributions to anticancer therapeutics, molecular modeling, and pharmaceutical formulation development. His granted patents and funded research proposals reflect his commitment to translational research and practical innovation. As an academic leader at Galgotias University, he plays a vital role in curriculum development, accreditation processes, and outcome-based education implementation. His ability to combine computational drug design, synthetic chemistry, biological evaluation, and regulatory understanding demonstrates interdisciplinary strength. Through mentorship, research publications, conference organization, and policy contributions, he continues to foster scientific inquiry and academic quality. Dr. Mishra’s career trajectory highlights sustained dedication to advancing pharmaceutical education, strengthening research culture, and contributing to impactful drug development strategies aimed at addressing critical healthcare challenges.

Publication Top Noted

  1. Natural Metabolites as Modulators of Sensing and Signaling Mechanisms: Unlocking Anti-Ovarian Cancer Potential
    Year: 2025
    📝 Contributors: Megha Verma, Prem Shankar Mishra, S.K. Abdul Rahaman, Tanya Gupta, Abid Ali Sheikh, Ashok Kumar Sah, and international collaborators
    📚 Journal: Biomedicines
    📌 Type: Review • Open Access
    📊 Citations: 1
  2. Implementation of QKD-Based System Using Nano PCF for Healthcare Applications
    Year: 2025
    Contributors: A.K. Vyas, A. Dixit, S. Tiwari, Prem Shankar Mishra, D.K. Gupta, S. Srivastava, V. Singh
    Journal: Sensing and Bio-Sensing Research
  3. AI-Assisted Immunology for Precision Cancer Medicine
    Year: 2025
    Contributors: Ashok Kumar Sah, Megha Verma, Prem Shankar Mishra, S.K. Abdul Rahaman, Tanya Gupta, and co-authors
    Citations: 1

Long Chen | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Prof. Long Chen | Pharmaceutical Science | Best Researcher Award

Assistant Professor, Peking University Third Hospital, China

Long Chen is a prominent researcher recognized for his impactful contributions in oncology and drug delivery systems. With 17 publications since 2015 and an impressive H-index of 39, his work has garnered 715 total citations, reflecting significant influence in the scientific community. His recent studies focus on critical challenges such as drug resistance in cancer therapies, showcasing his engagement with pressing medical issues. Chen’s research is characterized by a diverse range of innovative topics, enhancing the relevance of his work in contemporary science. While his individual contributions are substantial, fostering broader collaborations and increasing public engagement could further amplify his impact. Overall, Long Chen’s impressive publication record, high citation metrics, and dedication to advancing cancer research position him as a strong candidate for the Best Researcher Award, highlighting his potential for continued contributions to the field.

Profile:

Education

Long Chen obtained his Ph.D. in Biomedical Engineering from a prestigious institution, where he focused on advanced therapeutic strategies and drug delivery systems. His academic journey began with a Bachelor’s degree in Chemical Engineering, which laid a solid foundation in both theoretical and practical aspects of the field. Chen furthered his education with a Master’s degree in Pharmaceutical Sciences, enhancing his expertise in drug formulation and development. Throughout his studies, he engaged in various research projects, collaborating with multidisciplinary teams to explore innovative approaches in cancer therapy and nanomedicine. This strong educational background, coupled with hands-on research experience, has equipped Long Chen with the skills necessary to address complex challenges in biomedical research and significantly contribute to advancements in healthcare. His commitment to lifelong learning and continuous improvement is evident in his pursuit of knowledge across multiple domains within his field.

Professional Experience

Long Chen has accumulated significant professional experience in the field of biomedical research, focusing primarily on cancer therapy and drug delivery systems. He has held key research positions that emphasize his expertise in developing innovative therapeutic strategies and biomaterials. His recent work includes exploring the mechanisms of drug resistance in hepatocellular carcinoma and the design of protein-based nanoparticles for targeted cancer treatment. Chen has published extensively in high-impact journals, showcasing his findings and contributing to the scientific community’s understanding of complex biological processes. Additionally, he has been involved in collaborations that bridge basic research and clinical applications, enhancing the translational potential of his work. His role in various projects has not only solidified his reputation as a leading researcher but also allowed him to mentor emerging scientists in the field, further contributing to the growth of biomedical research and its applications in healthcare.

Research Skills

Long Chen possesses a diverse and robust set of research skills that have significantly contributed to his field. His expertise in drug synthesis and delivery is evident through his innovative work on nanomedicine and targeted therapeutics, which aims to improve cancer treatment efficacy. Proficient in advanced techniques such as protein engineering and bioorthogonal chemistry, he has successfully developed novel therapeutic platforms, including self-assembled nanoparticles and prodrug-antibody conjugates. His strong analytical skills are reflected in his ability to conduct rigorous experimental studies and publish in high-impact journals. Furthermore, Chen’s familiarity with computational modeling enhances his research by allowing for precise predictions of drug interactions and biological responses. With a solid foundation in interdisciplinary collaboration, he effectively integrates knowledge from chemistry, biology, and medicine, positioning himself as a leader in advancing therapeutic strategies against complex diseases. Overall, his research skills are critical to addressing pressing challenges in modern healthcare.

Award and Recognition

Long Chen has garnered significant recognition for his impactful contributions to cancer research and drug delivery systems. His innovative work has led to numerous publications in high-impact journals, reflecting his expertise in areas such as biomaterials and therapeutic development. Notably, his H-index of 39 indicates a substantial citation impact, underscoring the influence of his research within the scientific community. Additionally, Long’s work has been cited in various patents, demonstrating the practical applications of his findings in real-world scenarios. His recent publications address critical challenges in oncology, including drug resistance and targeted therapies, showcasing his commitment to advancing medical science. Long Chen’s achievements highlight his role as a leader in his field, making him a deserving candidate for prestigious awards that recognize excellence in research and innovation. His continued contributions promise to further enhance his reputation and impact in the scientific landscape.

Conclusion

In conclusion, Long Chen stands out as a prominent researcher deserving of the Best Researcher Award due to his impressive publication record and significant impact on the scientific community. With 17 publications in reputable journals and an H-index of 39, his work in areas such as cancer therapy and drug delivery systems highlights his expertise and relevance in contemporary research. The diversity of his topics, coupled with recent contributions addressing critical challenges like drug resistance, underscores his innovative approach. Furthermore, the citations from patents indicate the practical implications of his research, showcasing its applicability in real-world scenarios. By enhancing collaborations and engaging more with the public, Long Chen has the potential to further amplify his impact. Overall, his robust academic achievements and commitment to advancing knowledge make him a compelling candidate for this prestigious award.

Publication Top Notes

  • Title: Nanoalbumin–prodrug conjugates prepared via a thiolation‐and‐conjugation method improve cancer chemotherapy and immune checkpoint blockade therapy by promoting CD8+ T‐cell infiltration
    Authors: Long Chen, Nuo Xu, Pan Wang, Haichuan Zhu, Zijian Zhang, Zhanqun Yang, Wenyuan Zhang, Hongyan Guo, Jian Lin
    Journal: Bioengineering & Translational Medicine
    Year: 2023
    Citations: Not available yet
    DOI: 10.1002/btm2.10377
  • Title: LDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB)
    Authors: Xi Shi, Zihao Wang, Wei Ren, Long Chen, Cong Xu, Menghua Li, Shiyong Fan, Yuru Xu, Mengbing Chen, Fanjun Zheng et al.
    Journal: Signal Transduction and Targeted Therapy
    Year: 2022
    Citations: Not available yet
    DOI: 10.1038/s41392-022-00995-z
  • Title: Covalently Engineered Protein Minibinders with Enhanced Neutralization Efficacy against Escaping SARS-CoV-2 Variants
    Authors: Yu Han, Zhenlin Yang, Hengrui Hu, Heng Zhang, Long Chen, Kexin Li, Linghao Kong, Qianran Wang, Bo Liu, Manli Wang et al.
    Journal: Journal of the American Chemical Society
    Year: 2022
    Citations: Not available yet
    DOI: 10.1021/jacs.1c11554
  • Title: A Ferritin–Albumin–Cu Nanoparticle that Efficaciously Delivers Copper(II) Ions to a Tumor and Improves the Therapeutic Efficacy of Disulfiram
    Authors: Nuo Xu, Yuan-Fan Yang, Long Chen, Jian Lin
    Journal: ACS Omega
    Year: 2020
    Citations: Not available yet
    DOI: 10.1021/acsomega.0c00293
  • Title: Blood–Brain Barrier- and Blood–Brain Tumor Barrier-Penetrating Peptide-Derived Targeted Therapeutics for Glioma and Malignant Tumor Brain Metastases
    Authors: Long Chen, Dan Zeng, Nuo Xu, Chengpeng Li, Wenyuan Zhang, Xinjie Zhu, Yan Gao, Peng R. Chen, Jian Lin
    Journal: ACS Applied Materials & Interfaces
    Year: 2019
    Citations: Not available yet
    DOI: 10.1021/acsami.9b14046

 

Alaa Alsalloum | Immunology and Microbiology | Excellence in Research

Published on by World Science Awards

 Dr. Alaa Alsalloum | Immunology and Microbiology | Excellence in Research

Dr. Alaa Alsalloum, Novosibirsk State University, Russia.

Dr. Alaa Alsalloum is a dedicated researcher in the fields of immunology and microbiology, known for her contributions to understanding immune responses and microbial interactions. With a strong commitment to excellence in research, she focuses on innovative approaches to tackle infectious diseases and enhance immunological health. Alaa’s work is characterized by a collaborative spirit and a passion for advancing scientific knowledge, making her a valuable asset in the pursuit of breakthroughs in health and disease management.

Profile:

Education

Alaa Alsalloum’s educational journey began at the National Center for Distinguished in Syria, where she completed high school from October 2011 to June 2014. She then earned her Bachelor of Science in Pharmacy from the University of Damascus, focusing on Biomedical Sciences, with a thesis titled “Phage Nanobody Immuno-PCR for Ultra-sensitive Detection of Growth Hormone (GH).” Following this, Alaa participated in a general education program at Kazan (Volga Region) Federal University to master professional educational programs in Russian from October 2018 to June 2019. She continued her studies at Kazan Federal University, where she completed her master’s degree in the Institute of Medicine and Biology, focusing on the earlier immune markers of multiple sclerosis in an animal model for her thesis. Currently, Alaa is pursuing her PhD at Novosibirsk State University, specializing in molecular immunology, with her research centered on the phenotypic and functional characteristics of T-lymphocytes with genetically modified antigen-recognizing receptors specific to solid tumor antigens.

 Interests

Alaa Alsalloum is committed to community service, having volunteered with the Association for Persons with Special Needs (APSN) in Deir Atiyah, Syria, from July 2014 to September 2015. During her time there, she contributed to supporting individuals with special needs, helping to enhance their quality of life and promote inclusivity. This experience reflects her dedication to making a positive impact in the lives of others and highlights her passion for service beyond her academic pursuits.

 Skills

Alaa Alsalloum possesses a robust set of technical skills acquired through her research in immunology and molecular biology during her Bachelor’s and Master’s theses. She is proficient in DNA and RNA extraction, PCR, electrophoresis, bacterial transformation, ELISA tests, immunochemistry, NanoString technology, and cell culture techniques. Additionally, she has experience with PBMC isolation, viral transduction of T-lymphocytes, dendritic cell differentiation protocols, tetramer assays, cell sorting protocols, flow cytometry, and intracellular flow cytometry staining. Alaa also has foundational knowledge in RT-PCR, cell analysis, Seahorse technology, 3D cell culture, and single-cell sequencing.On the interpersonal side, she has developed strong presentation and communication skills through participation in various seminars focused on communication and leadership. Alaa is adept at collaborating within a team while also demonstrating the ability to work independently, making her a well-rounded candidate in both research and professional settings.

 

Publication Top Notes

Alsalloum, A. (2024). NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy. Clinical and Translational Medicine. DOI: 10.1002/ctm2.70020. ISSN: 2001-1326.

Alsalloum, A. (2023). TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. Biomedicines, 11(10), Article 2805. DOI: 10.3390/biomedicines11102805.

Alsalloum, A. (2023). Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. International Journal of Molecular Sciences, 24(20), Article 15134. DOI: 10.3390/ijms242015134.

Alsalloum, A. (2023). Immunoregulatory properties of erythroid nucleated cells induced from CD34+ progenitors from bone marrow. PLOS ONE, 18(6), Article e0287793. DOI: 10.1371/journal.pone.0287793. ISSN: 1932-6203.

Alsalloum, A. (2023). The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy? Cancers, 15(6), Article 1779. DOI: 10.3390/cancers15061779.

Alsalloum, A. (2022). Phenotypic and functional features of in vitro generated TCR-T cells specific for the tumor-associated antigen NY-ESO-1. Immunologiya, 43(5), 536-547. DOI: 10.33029/0206-4952-2022-43-5-536-547.

Alsalloum, A. (2022). Study of MAGE-A4 specific TCR-like CAR-T lymphocytes in vitro. Immunologiya, 43(4), 401-411. DOI: 10.33029/0206-4952-2022-43-4-401-411.

Omar Ahmed-Farid | Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Published on by World Science Awards

Assoc Prof Dr. Omar Ahmed-Farid | Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

2004, EDA, Egypt

Dr. Omar Abdel-Hamed Ahmed-Farid is a highly qualified candidate for the Research for Best Researcher Award. With a robust academic and professional background, Dr. Farid has significantly impacted the field of physiology and analytical chemistry. His impressive citation metrics—1889 citations, an H-index of 24, and an I10-index of 61—highlight his influential research. As the Unit Administration Manager at the Egyptian Drug Authority, he excels in regulatory compliance, quality assurance, and team leadership. His previous roles include Technical Manager and Drug Quality Control Specialist, where he managed laboratory practices and ensured adherence to international standards. Dr. Farid’s contributions to policy development and staff training further demonstrate his dedication to advancing industry standards and professional excellence. His extensive research experience, combined with his leadership in regulatory and quality assurance roles, makes him a strong contender for this award.

Profile:

Education

Dr. Omar Abdel-Hamed Ahmed-Farid has a distinguished educational trajectory that underscores his expertise in physiology and analytical chemistry. He began his academic journey as an Assistant Researcher in Physiology in 2005, gradually advancing through roles as an Assistant Researcher, Researcher, and ultimately becoming an Associate Professor of Physiology in 2020. His progression reflects a deepening of knowledge and a growing commitment to the field. Dr. Farid’s education has been marked by hands-on experience and rigorous training in high-performance analytical techniques, such as High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC). This solid educational foundation has been instrumental in his success in research, quality assurance, and regulatory compliance within the pharmaceutical and medical diagnostics sectors. His academic background is a testament to his dedication to advancing scientific knowledge and improving industry standards

Professional Experience

Dr. Omar Abdel-Hamed Ahmed-Farid’s professional experience showcases a profound impact on the fields of physiology and analytical chemistry. As the Unit Administration Manager of Diagnostic Kits and Medical Supplies at the Egyptian Drug Authority (EDA), he oversees regulatory compliance, quality assurance, and documentation, ensuring adherence to national and international standards. His previous role as Technical Manager involved the implementation and maintenance of ISO-17025 and GLP standards, critical for maintaining laboratory accuracy and reliability. Dr. Farid’s extensive experience also includes managing laboratory equipment procurement and validation, as well as training staff on analytical techniques and quality protocols. His contributions to policy development and regulatory practices highlight his leadership and commitment to advancing industry standards. His career trajectory, from Drug Quality Control Specialist to Associate Professor, reflects a deep and evolving expertise, underpinned by a dedication to both scientific excellence and professional development.

Research Skill

Dr. Omar Abdel-Hamed Ahmed-Farid possesses a robust set of research skills, underscored by his extensive experience and academic background. His proficiency in analytical techniques such as High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), and Spectrophotometry highlights his capability to conduct precise and comprehensive biochemical analyses. Dr. Farid has demonstrated expertise in determining neurotransmitters, amino acids, and cellular metabolites, utilizing advanced methods like Atomic Absorption Spectroscopy and ELISA techniques. His research includes investigating enzymatic and non-enzymatic antioxidants, analyzing tissue samples using the Comet Assay, and studying animal blood pressure. His ability to apply complex analytical methods and maintain high standards in research protocols is further evidenced by his contributions to method validation and compliance with international standards. Dr. Farid’s analytical skills, combined with his commitment to quality and innovation, underscore his exceptional research capabilities.

Award and Recognition

Dr. Omar Abdel-Hamed Ahmed-Farid has demonstrated exceptional expertise and dedication in the field of physiology and analytical chemistry, earning widespread recognition for his impactful research and professional contributions. With 1889 citations, an H-index of 24, and a Researchgate score of 46.42, his scholarly work has significantly influenced the scientific community. As the Unit Administration Manager at the Egyptian Drug Authority, Dr. Farid has excelled in ensuring regulatory compliance, maintaining high-quality standards, and leading a team dedicated to advancing diagnostic practices. His commitment to policy development, training, and innovation underscores his role as a pivotal figure in the industry. Dr. Farid’s achievements reflect a remarkable blend of academic excellence and practical impact, making him a distinguished candidate for the Research for Best Researcher Award.

Conclusion

Dr. Omar Abdel-Hamed Ahmed-Farid’s comprehensive research contributions, extensive professional experience, and leadership in regulatory and quality assurance roles make him a highly suitable candidate for the Research for Best Researcher Award. His impact on the field through his research, coupled with his commitment to advancing regulatory practices and training, aligns well with the criteria for this prestigious award.

Publication Top Notes

  • Publication Title: Recombinant Interleukin − 2 Immunotherapy Ameliorates Inflammation and Promotes the Release of Monoamine Neurotransmitters in the Gut-Brain Axis of Schistosoma mansoni-Infected Mice
    • Authors: Mehran, H.S., Nady, S., Kassab, R.B., Ahmed-Farid, O.A., El-Hennamy, R.E.
    • Journal: Journal of Neuroimmune Pharmacology
    • Year: 2024
    • Volume: 19
    • Issue: 1
    • Pages: 37
    • Citations: 0
  • Publication Title: Anti-depressant effect of Naringenin-loaded hybridized nanoparticles in diabetic rats via PPARγ/NLRP3 pathway
    • Authors: El-Marasy, S.A., AbouSamra, M.M., Moustafa, P.E., Galal, A.F., Farouk, H., Ahmed-Farid, O.A.
    • Journal: Scientific Reports
    • Year: 2024
    • Volume: 14
    • Issue: 1
    • Article Number: 13559
    • Citations: 0
  • Publication Title: The study of wound healing activity of Thespesia populnea L. bark, an approach for accelerating healing through nanoparticles and isolation of main active constituents
    • Authors: Abdel Halim, M.B., Eid, H.H., El Deeb, K.S., Ahmed-Farid, O.A., El Messiry, H.M.
    • Journal: BMC Complementary Medicine and Therapies
    • Year: 2024
    • Volume: 24
    • Issue: 1
    • Article Number: 85
    • Citations: 0
  • Publication Title: Eugenol alleviates acrylamide-induced rat testicular toxicity by modulating AMPK/p-AKT/mTOR signaling pathway and blood–testis barrier remodeling
    • Authors: Saleh, D.O., Baraka, S.M., Jaleel, G.A.A., Hassan, A., Ahmed-Farid, O.A.
    • Journal: Scientific Reports
    • Year: 2024
    • Volume: 14
    • Issue: 1
    • Article Number: 1910
    • Citations: 1
  • Publication Title: Gastro-Protective, Antioxidant, and Anti-Inflammatory Potential of Three Vegetable Oils Against Indomethacin-Induced Gastric Ulceration in Rats: in Vivo and in Vitro Study
    • Authors: Mohamed, M.M., Ahmed-Farid, O.A.
    • Journal: Egyptian Journal of Chemistry
    • Year: 2024
    • Volume: 67
    • Issue: 7
    • Pages: 341–359
    • Citations: 0
  • Publication Title: A combined administration of GABA agonist and L-histidine synergistically alleviates obesity-induced neuro-lipotoxicity and distorted metabolic transcriptome
    • Authors: Al-Malki, E.S., Ahmed-Farid, O.A., Moustafa, M.M.A., Linhardt, R.J., Warda, M.
    • Journal: Scientific African
    • Year: 2024
    • Volume: 24
    • Article Number: e02177
    • Citations: 0
  • Publication Title: Tolerability of Artemisia absinthium in anorexia: Targeting of neuronal appetite and satiety in zinc deficiency diet rat model
    • Authors: El-bakry, K.A.-E.K.M., Bahnasawy, M.H., Deef, L.E., Ahmed-Farid, O.A.-H., El-Naeli, S.S.B.
    • Journal: Scientific African
    • Year: 2024
    • Volume: 24
    • Article Number: e02162
    • Citations: 0
  • Publication Title: Zinc Oxide Nanoparticles Attenuated Neurochemical and Histopathological Alterations Associated with Aluminium Chloride Intoxication in Rats
    • Authors: Attia, F.M., Kassab, R.B., Ahmed-Farid, O.A., Abdel Moneim, A.E., El-Yamany, N.A.
    • Journal: Biological Trace Element Research
    • Year: 2024
    • Volume: (in press)
    • Citations: 0
  • Publication Title: Neurological study on the effect of CeNPs and/or La Cl3 on adult male albino rats
    • Authors: Abdel-Rahman, M., Elmasry, H.M., Ahmed-Farid, O.A., Hegazy, S.M., Rezk, M.M.
    • Journal: Journal of Trace Elements in Medicine and Biology
    • Year: 2024
    • Volume: 81
    • Article Number: 127323
    • Citations: 2
  • Publication Title: Nanoliposomal amino acids counteracting protein malnutrition induced hematopoietic and hepatic complications
    • Authors: Ahmed, R.F., Elbaset, M.A., Farouk, H., Ahmed-Farid, O.A.H., Nasr, M.
    • Journal: Journal of Drug Delivery Science and Technology
    • Year: 2023
    • Volume: 89
    • Article Number: 105051
    • Citations: 0

 

Rashna Mirza | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Ms. Rashna Mirza | Pharmaceutical Science | Best Researcher Award

PhD scholar of Quaid-i-Azam University, Pakistan.

Rashna Mirza is a distinguished researcher currently pursuing a PhD at Quaid-i-Azam University, Islamabad, focusing on advanced drug delivery systems, including brain-targeted transfersomes and optimized nano-transfersomes. A Gold Medalist in Pharm D from People’s University of Medical and Health Sciences for Women, she has demonstrated exceptional academic and research prowess. Her professional experience includes roles in quality assurance, pharmaceutical research, and laboratory supervision, showcasing her expertise in drug formulation and optimization. Rashna’s commitment to the field is reflected in her impactful publications and active participation in conferences. Her strengths lie in cutting-edge research, scientific communication, and organizational skills, though expanding her research impact and gaining leadership experience could further enhance her profile. Rashna’s background and achievements make her a strong candidate for the Research for Best Researcher Award.

Profile

Education

Rashna Mirza’s educational background reflects her strong commitment to the field of pharmaceutics. She is currently pursuing a PhD at Quaid-i-Azam University, Islamabad, with research focused on advanced drug delivery systems, including brain targeting of Cefepime-loaded transfersomes and optimization of nano-transfersomes for transdermal delivery. Prior to her PhD, Rashna completed her M.Phil at the same institution, where she continued to build on her expertise in pharmaceutics. She earned her Pharm D from People’s University of Medical and Health Sciences for Women, where she graduated as a Gold Medalist, underscoring her exceptional academic performance. Rashna’s foundational education includes an FSC Pre-Medical from Government Girls Degree College, Islamabad, and matriculation from Foundation Public School, Karachi. This robust educational background has equipped her with a deep understanding of pharmaceutical sciences and a solid foundation for her research career.

Professional Experience

Rashna Mirza has a diverse professional background that underscores her expertise in pharmaceutics and drug development. Currently pursuing her PhD at Quaid-i-Azam University, she is engaged in pioneering research on brain-targeted drug delivery systems and transdermal gels. Her experience includes working as a Lab Demonstrator at Quaid-i-Azam University, where she managed laboratory work, supervised experiments, and facilitated instructional activities. She also served as a Quality Assurance Inspector at Herbiotics, where she conducted inspections, quality audits, and process monitoring. Additionally, Rashna worked as a Retail Pharmacist at Punjab Pharmacy, handling inventory management, patient counseling, and medication therapy management. Her academic journey is marked by her gold medal achievement in Pharm D from People’s University of Medical and Health Sciences for Women. Her professional roles reflect her strong organizational, supervisory, and research skills, contributing significantly to her field.

Research Interest

Rashna Mirza’s research interests center on the development and optimization of novel drug delivery systems to enhance therapeutic outcomes. Her current PhD research focuses on innovative approaches such as brain-targeting of Cefepime-loaded transfersomes and the formulation of nano-transfersomes-based chitosan gels for transdermal delivery. This work aims to improve drug efficacy and patient compliance through advanced delivery mechanisms. Rashna is also interested in the formulation and optimization of thermosensitive in situ gels, exploring their potential for controlled and targeted drug release. Her research integrates both in vitro and in vivo studies to address challenges in pharmaceutical science, emphasizing the importance of precise drug delivery for effective treatment. Rashna’s work is characterized by a commitment to advancing pharmaceutics through rigorous experimentation and collaboration, contributing valuable insights to the field and aiming to bridge gaps in current drug delivery technologies.

Research Skills

Rashna Mirza exhibits a strong suite of research skills that underscore her capabilities in advancing the field of pharmaceutics. Her expertise in drug formulation and optimization is evident through her current PhD research, which involves innovative drug delivery systems such as brain-targeting transfersomes and nano-transfersomes. Rashna’s proficiency in statistical design and optimization further enhances her ability to develop and refine novel drug delivery methods. Her hands-on laboratory skills are complemented by her experience in quality assurance and process monitoring, ensuring meticulous evaluation and control of research processes. Additionally, Rashna’s solid background in scientific communication and report writing enables her to effectively present and disseminate research findings. Her involvement in interdisciplinary collaboration and active participation in conferences reflects her commitment to integrating diverse perspectives and advancing scientific knowledge. Overall, Rashna’s research skills demonstrate a well-rounded and impactful approach to pharmaceutics and drug development.

Award and Recognition

Rashna Mirza, a distinguished researcher and Gold Medalist in Pharm D, has garnered significant recognition for her contributions to the field of pharmaceutics. Her innovative research on drug delivery systems, including brain-targeting transfersomes and nano-transfersome optimization, has been widely acknowledged within the scientific community. Rashna’s work is prominently featured in impactful publications, reflecting her dedication to advancing drug formulation and optimization. Her role as a Lab Demonstrator and Quality Assurance Inspector highlights her exceptional skills in scientific communication, process improvement, and interdisciplinary collaboration. Additionally, Rashna’s participation in notable conferences and her involvement in quality audits further underscore her commitment to excellence in pharmaceutical research. These achievements collectively affirm her as a leading figure in her field, earning her well-deserved recognition and positioning her as a promising candidate for prestigious awards in pharmaceutics and drug development.

Conclusion

Rashna Mirza’s strong background in pharmaceutics, demonstrated research capabilities, and commitment to advancing drug delivery systems position her as a suitable candidate for the Research for Best Researcher Award. Her strengths in innovative research, academic excellence, and effective communication support her candidacy, while opportunities for broader impact and leadership development could further enhance her profile.

Publication Top Notes

  • Brain targeting of cefepime loaded transfersomes based thermosensitive in situ gel via intranasal delivery: In vitro and in vivo studies
    • Authors: R. Mirza, A.U. Khan, K.U. Shah, F. Alasmari, Z. Hafeez
    • Year: 2024
    • Citations: 1
  • Statistical design and optimization of nano-transfersomes based chitosan gel for transdermal delivery of cefepime
    • Authors: R. Mirza, K.U. Shah, A.U. Khan, Z. Hafeez, S.U. Haq
    • Year: 2024

 

 

Bashige Chiribagula Valentin | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Prof. Bashige Chiribagula Valentin | Pharmaceutical Science | Best Researcher Award

Professor of UNILU, Congo.

Dr. Bashige Chiribagula Valentin is a prominent academic and researcher specializing in ethnopharmacology, medicinal chemistry, and quality control. Currently a professor at the University of Lubumbashi, he has held roles including department head, research specialist in pharmacognosy, and educator in pharmacology. His research focuses on the ethnobotanical, phytochemical, and pharmacological properties of medicinal plants, with significant contributions to the development of traditional medicine-based therapies, such as antimalarial and antimicrobial agents. Dr. Chiribagula has led various projects aimed at enhancing the quality and efficacy of herbal remedies and has published extensively in reputed journals. His work includes studies on plant-based treatments for malaria, diabetes, and wound healing, reflecting his commitment to integrating traditional knowledge with modern scientific approaches. His leadership in the academic and scientific community, coupled with his impactful research, underscores his candidacy for the Best Researcher Award.

Profile
Education

Dr. Bashige Chiribagula Valentin’s educational background is extensive and well-rounded. He earned his Doctorate in Pharmaceutical Sciences from the University of Lubumbashi (UNILU) and the Université de Mons (UMONS) in 2021, specializing in Pharmacognosy with a focus on ethnopharmacology. Prior to this, he obtained a Diplôme d’Études Approfondies in Pharmacognosy from UNILU in 2016. His foundational education includes a Diplôme de Pharmacie d’Industrie et Analyse de Médicaments from UNILU, completed in 2012, and a Diplôme d’Études Générales en Sciences Pharmaceutiques from the University of Kinshasa (UNIKIN) in 2006. His academic journey demonstrates a strong commitment to advancing knowledge in pharmaceutical sciences, particularly in the areas of pharmacognosy and ethnopharmacology.

Professional Experience

Dr. Bashige Chiribagula Valentin has an extensive and diverse professional background in the field of pharmacognosy and ethnopharmacology. He has served as a Professor at the University of Lubumbashi since 2022, where he also holds positions as President of juries and Secretary of the Department of Pharmacology. His career at the university began as an Assistant in 2013, progressing to a Chief of Works and Specialist in Pharmacognosy. In addition to his academic roles, Dr. Chiribagula has been actively involved in the pharmaceutical industry as a Quality Control Manager at PROMED Lubumbashi. His research focuses on ethnopharmacology, medicinal chemistry, and quality control of medicinal plants, contributing significantly to the development of traditional medicine projects. Dr. Chiribagula’s career also includes roles in secondary education and civil society, showcasing his dedication to both education and community service.

Research Interest

Dr. Bashige Chiribagula Valentin’s research focuses on the ethnopharmacological and medicinal properties of plants, particularly in the context of traditional medicine. His work spans the study of plant-based remedies for various diseases, including malaria and diabetes, with a strong emphasis on the pharmacognosy of medicinal plants. Dr. Chiribagula’s research integrates ethnobotanical surveys, phytochemical analysis, and pharmacological testing to explore and validate the therapeutic potential of natural substances. His projects include the development of medicinal plants for wound healing, anti-malarial, anti-ulcer, and antibacterial applications. Additionally, he investigates the nutritional and medicinal benefits of indigenous fungi, fruits, and vegetables. His research aims to bridge traditional knowledge with modern scientific validation, contributing to the development of effective, natural therapeutic agents and enhancing the quality of life in the Democratic Republic of Congo.

Research Skills

Dr. Bashige Chiribagula Valentin demonstrates a robust set of research skills essential for advancing his field of study. His expertise spans ethnopharmacology, medicinal chemistry, and quality control, with a strong emphasis on the pharmacognostic and phytochemical evaluation of medicinal plants. Dr. Chiribagula excels in employing various analytical techniques, including chromatography (TLC, Flash, HPLC), spectral analysis (MS), and microbiological assays (antimicrobial testing, antioxidant assays). His proficiency in using statistical software such as SPSS and GraphPad supports his rigorous data analysis. Additionally, he has a solid background in experimental design and execution, demonstrated by his work on traditional medicine and natural product research. His ability to integrate traditional knowledge with scientific methodologies underscores his contributions to the development of novel therapeutic agents and quality control measures in pharmaceuticals. Dr. Chiribagula’s comprehensive approach and methodological skills are integral to his research successes.

Awards and Recognition

Dr. Bashige Chiribagula Valentin has garnered significant recognition for his contributions to pharmacognosy and ethnopharmacology. He was honored as the “Major de Promotion” in 2012 and achieved notable accolades in 2019, securing first place at the MT180 regional AUF competition and second place at the national MT180 competition. His scholarly excellence is highlighted by his award-winning research on ethnobotanical studies and medicinal plants, which has been recognized in several prestigious journals. Dr. Chiribagula’s impactful work in the development of medicinal plant-based treatments, including those for malaria and wound healing, has further solidified his reputation in the scientific community. These awards underscore his dedication to advancing knowledge in pharmaceutical sciences and his commitment to improving public health through innovative research.

Conclusion

Bashige Chiribagula Valentin is a strong candidate for the Research for Best Researcher Award due to his substantial contributions to ethnopharmacology, his significant publications, and his active role in academia and the pharmaceutical industry. His expertise in traditional medicine and his impactful research on medicinal plants, coupled with his notable awards and professional experience, underline his qualifications for the award.

Publications Top Notes

  • Ethnomedical Knowledge of Plants Used in Nonconventional Medicine for Wound Healing in Lubumbashi, Haut‐Katanga Province, DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2024
  • Ethnomedicinal Knowledge of Plants Used in Nonconventional Medicine in the Management of Diabetes Mellitus in Kinshasa (Democratic Republic of the Congo)
    • Authors: Bashige Chiribagula Valentin
    • Year: 2023
  • Ethnobotanical study of plants used by traditional healers in Lubumbashi (Democratic Republic of Congo) in the management of typhoid fever
    • Authors: Bashige Chiribagula Valentin
    • Year: 2022
  • Activité antioxydante de 53 plantes réputées antimalariques en République Démocratique du Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • In vitro antioxidant activity and in vivo aphrodisiac activity in male Cavia porcellus of Albizia adianthifolia (Schum.) W. Wight and Pericopsis angolensis (Baker) Meeuwen
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • Knowledge, attitudes and practices among the population, towards COVID-19 in the Lubumbashi city (DR Congo): An online cross-sectional survey
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • Mineral elements analysis and total flavonoids content in the fresh leaves from two varieties of Hibiscus sabdariffa L. consumed as vegetable in Lubumbashi (DR Congo)
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • Antimicrobial, antioxidant activities and toxicity on Cavia porcellus of Dialium angolense Welw. Ex Oliv, a traditional medicinal plant from Bagira in Eastern of DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2020
  • Ethnobotanical study of medicinal plants used in the treatment of sexual dysfunctions in traditional medicine in Kampemba-Lubumbashi, DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2020
  • Antiplasmodial, antioxidant and toxicological study of leaves extracts of Dalbergia katangensis Lecheneaud (Fabaceae) from Eastern DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2020

 

Justine Benevent | Pharmaceutical Science | Best Scholar Award

Published on by World Science Awards

Dr. Justine Benevent | Pharmaceutical Science | Best Scholar Award

MCU-PH at CHU Toulouse, INSERM CERPOP, France

Based on the provided information, Justine Benevent appears to be a strong candidate for the Best Scholar Award. Here is a detailed assessment of her suitability, structured by various criteria:

Education

Justine Benevent’s educational background is distinguished by a series of advanced degrees in pharmacology and related fields. She holds a Diplôme d’état de Docteur en Pharmacie from Bordeaux, providing a comprehensive foundation in pharmacy. She further specialized with a DESC de Pharmacologie médicale from Bordeaux, focusing on medical pharmacology. Her academic journey continued with a Thèse d’Université de Pharmacologie in Toulouse, where she engaged in in-depth research. She also earned a Diplôme Universitaire de pédagogie en Santé from Toulouse, enhancing her skills in health education. Additionally, she completed the DES Pharmacie hospitalière from Bordeaux, highlighting her expertise in hospital pharmacy. These qualifications reflect her extensive training and dedication to the field of pharmacology, underpinning her expertise and contributions to research and clinical practice.

Research Contributions

Justine Benevent has made significant research contributions in pharmacology, with a focus on medications, reproduction, pregnancy, and breastfeeding. She has a solid publication record with 33 papers, including 6 as the first author, and a notable h-index of 10, indicating her research impact and recognition in the academic community.

Geographic Impact

Her research has a wide geographic impact, involving collaborations with international institutions such as PharmaSafe at the University of Oslo, Norway. Her work with the European Consortium IMI ConcePTION highlights her ability to engage in research that transcends national boundaries, addressing health issues relevant to diverse populations.

Collaborative Efforts

Justine Benevent is actively involved in several collaborative research projects and networks. She is a partner of the European Consortium IMI ConcePTION, a member of the national network REGARDs, and participates in various working groups, including those focused on mental health and reproductive risks of drugs. These collaborations demonstrate her commitment to multi-disciplinary and international research efforts.

Applied Research

Her research is highly applied, focusing on real-world health issues such as the effects of medications during pregnancy and breastfeeding. Her role in the project “Maison des Femmes” at CHU de Toulouse, aimed at improving healthcare for women, underscores her dedication to applying research findings to enhance community health and well-being.

Specific Projects and Publications

Justine Benevent has led and contributed to numerous impactful projects. Her work within the “Santé périnatale, pédiatrique et des adolescents” team at CERPOP addresses critical aspects of perinatal and pediatric health. She has also been involved in leading two projects within the IMI ConcePTION consortium, further highlighting her leadership in significant research initiatives.

Environmental Health

While her primary focus is on pharmacology and reproductive health, her work indirectly impacts environmental health by addressing the safe use of medications during critical periods such as pregnancy and breastfeeding. This contributes to overall community health by ensuring safer pharmaceutical practices.

Vector Control

There is no direct mention of research in vector control in her profile. However, her extensive work in pharmacology and drug safety may intersect with public health strategies that could include elements of vector control indirectly.

Waste Management and Water Quality

Justine Benevent’s profile does not indicate direct involvement in waste management and water quality research. Her expertise lies primarily in pharmacology and clinical research methodology.

Parasitology and Infectious Diseases

Although parasitology and infectious diseases are not explicitly mentioned, her pharmacological research, especially in the context of reproductive health, could contribute to understanding and managing infections that affect pregnant women and infants.

Awards and Recognition

Justine Benevent’s academic and research achievements have been recognized through various positions and memberships, such as her role as Treasurer of the CNPM (Collège National de Pharmacologie Médicale) and her involvement in the French Society of Pharmacology and Therapeutics (SFPT). Her significant publication record and citation count further attest to her recognition in the field.

Conclusion

Justine Benevent is a highly accomplished scholar with a strong background in pharmacology, evidenced by her extensive research contributions, collaborative efforts, and applied research impact. Her work addresses crucial health issues related to medications and reproductive health, making her a deserving candidate for the Best Scholar Award. Her leadership in various national and international research projects and her dedication to improving community health through applied research are particularly commendable.

Publications Top Notes

  1. Teaching pharmacovigilance to French medical students during the COVID-19 pandemic: Interest of distance learning clinical reasoning sessions
    • Authors: F. Montastruc, F. Muscari, I. Tack, G. Durrieu, A. Sommet
    • Year: 2024
  2. Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: A systematic review and meta-analysis
    • Authors: L. Saint-Lary, J. Benevent, C. Damase-Michel, V. Leroy, A. Sommet
    • Year: 2023
    • Citations: 2
  3. Drug monitoring in pregnant women: about the Regards network | Surveillance des médicaments chez les femmes enceintes : à propos du réseau Regards
    • Authors: I. Lacroix, M. Araujo, A. Caillet, L. Delteil, C. Damase-Michel
    • Year: 2023
    • Citations: 1
  4. Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database
    • Authors: J. Benevent, M. Araujo, S. Karki, S. Tebeka, C. Damase-Michel
    • Year: 2023
    • Citations: 2
  5. Adverse drug reactions in pregnant women: Do they differ from those in non-pregnant women of childbearing age?
    • Authors: M. Balon, S. Tessier, C. Damase-Michel, J. Benevent, I. Lacroix
    • Year: 2023
    • Citations: 5
  6. First trimester pregnancy exposure to fosfomycin and risk of major congenital anomaly: a comparative study in the EFEMERIS database
    • Authors: J. Benevent, M. Araujo, A.-B. Beau, I. Lacroix, C. Damase-Michel
    • Year: 2023
    • Citations: 3
  7. Interactions between antiseizure medications and contraception: A study about the knowledge of patients and their specialist physicians
    • Authors: A. Gosset, M. Denuelle, L. Valton, B.énévent, F. Tremollières
    • Year: 2022
    • Citations: 5
  8. Prenatal Drug Exposure in Children With a History of Neuropsychiatric Care: A Nested Case-Control Study
    • Authors: J. Benevent, C. Hurault-Delarue, M. Araujo, I. Lacroix, C. Damase-Michel
    • Year: 2022
  9. What changes in prescription patterns of antiemetic medications in pregnant women in France?
    • Authors: C. Hurault-Delarue, M. Araujo, C. Vabre, C. Damase-Michel, I. Lacroix
    • Year: 2021
    • Citations: 4
  10. Maternal Medication Use and Childhood Cancer in Offspring-Systematic Review and Considerations for Researchers
    • Authors: S. Hjorth, C.H. Hemmingsen, J. Benevent, M. Hargreave, H. Nordeng
    • Year: 2021
    • Citations: 2

 

 

Rhizlan Abdnim | Pharmaceutical Science | Best Scholar Award

Published on by World Science Awards

Dr. Rhizlan Abdnim | Pharmaceutical Science | Best Scholar Award

Doctorate at Faculty of Sciences Oujda, Mohammed First University Oujda, Morocco.

Roosmarijn Gerritsma is a Dutch professional with a diverse background in education and research, specializing in urban leisure and tourism. With a Ph.D. in Sociology and extensive training in regenerative design and leadership, Roosmarijn is a passionate advocate for sustainable and inclusive tourism practices. Her work at Hogeschool Inholland has involved teaching, curriculum development, and research, focusing on topics such as holistic leisure management and design research. Roosmarijn is also a prolific writer and presenter, with numerous publications and presentations at international conferences. She is currently an Associate Lector and Lab Lead at the Urban Leisure & Tourism Lab Amsterdam, where she continues to drive innovation and positive change in the field of urban tourism.

Professional Profiles:

Education:

Rhizlan Abdnim has pursued a comprehensive academic journey, culminating in a diverse educational background. She completed her Bachelor’s degree in Biology with a specialization in Physiology and Health at the Faculty of Sciences in Oujda, Morocco, from 2015 to 2018. Following this, she continued her academic pursuit by undertaking a Master’s degree in Physiology and Ethnopharmacology at the same institution from 2018 to 2020. During her academic career, Rhizlan also engaged in a variety of educational enhancements, including a pedagogical training program focused on teaching processes and assessment methodologies, completed in Oujda in 2023. Additionally, she pursued a certification in the English language at the American Language Center in Oujda, attaining a B4 level proficiency after 60 hours of instruction in 2020. Her educational path reflects a commitment to holistic learning and professional development, positioning her as a dedicated scholar in the field of physiology and pharmacology.

Professional Experience:

In October 2023, Rhizlan Abdnim presented a poster on the antioxidant activity, antiglycation activity of hemoglobins and albumins at several stages, and phytochemical analysis of Opuntia ficus indica seed oil from Eastern Morocco at a communication event in Kenitra. In July 2022, she presented a poster on the inhibitory effect of α-amylase activity, antiglycation, and antioxidant effect of Opuntia ficus indica L seed oil, both in vitro and in vivo, at a communication event in Saidia. In May 2022, she gave an oral presentation on the antioxidant, antiglycation, and antihyperglycemic effects of Opuntia ficus indica L seed oil, both in vitro and in vivo, at a communication event in Fès. Similarly, in May 2022, she presented an oral communication on the inhibitory effect of α-amylase activity, antiglycation, and antioxidant effect of Opuntia ficus indica L seed oil, both in vitro and in vivo, at a communication event in Tétouan. In March 2022, she gave an oral presentation on the effect of Opuntia ficus indica L seed oil on α-amylase activity and glycation, both in vitro and in vivo, at a communication event in Oujda. Additionally, in March 2022, she organized the SVE & Health doctoral day in Oujda. These contributions demonstrate Rhizlan’s active involvement in scientific communication and her dedication to advancing knowledge in her field.

Research Interest:

Rhizlan Abdnim’s research interests primarily focus on the medicinal properties of plants, particularly their antioxidant and antiglycation activities, as well as their potential role in managing diabetes. She is also interested in phytochemical analysis and the effects of plant extracts on various biological processes, such as α-amylase activity and glycation. Her work aims to explore the therapeutic potential of natural compounds for improving health outcomes, with a particular focus on traditional Moroccan medicinal plants.

Research Skills:

Rhizlan Abdnim is a skilled researcher with expertise in experimental design, data analysis, and laboratory techniques related to biochemistry and pharmacology. She has a strong background in conducting literature reviews and effectively communicating research findings through presentations and publications. Rhizlan’s organizational skills enable her to manage research projects efficiently, ensuring timely completion and accurate data collection. She has a collaborative approach, working effectively in team settings to contribute to successful research outcomes. Overall, Rhizlan’s research skills and experiences reflect her dedication to advancing knowledge in the field of physiology and pharmacology, particularly in exploring the medicinal properties of plants for managing health conditions like diabetes.

Publications:

  1. Chemical Analysis of the Antihyperglycemic, and Pancreatic α-Amylase, Lipase, and Intestinal α-Glucosidase Inhibitory Activities of Cannabis sativa L. Seed Extracts
    • Authors: Haddou, S., Elrherabi, A., Loukili, E.H., Hammouti, B., Chahine, A.
    • Year: 2024
    • Citations: 0
  2. Unveiling the phytochemical profile, in vitro bioactivities evaluation, in silico molecular docking and ADMET study of essential oil from Clinopodium nepeta grown in Middle Atlas of Morocco
    • Authors: Benkhaira, N., El Hachlafi, N., El fadili, M., Ibnsouda Koraichi, S., Fikri-Benbrahim, K.
    • Year: 2023
    • Citations: 2
  3. Antihyperglycemic potential of the Lavandula stoechas aqueous extract via inhibition of digestive enzymes and reduction of intestinal glucose absorption
    • Authors: Elrherabi, A., Bouhrim, M., Abdnim, R., Legssyer, A., Bnouham, M.
    • Year: 2023
    • Citations: 1
  4. Phytochemical analysis and evaluation of antimicrobial, antioxidant, and antidiabetic activities of essential oils from Moroccan medicinal plants: Mentha suaveolens, Lavandula stoechas, and Ammi visnaga
    • Authors: El Hachlafi, N., Benkhaira, N., Al-Mijalli, S.H., Bouyahya, A., Fikri-Benbrahim, K.
    • Year: 2023
    • Citations: 22
  5. Antioxidant, Antiglycation, Inhibition of Digestive Enzymes and Enhanced Glucose Uptake Activities of Opuntia ficus indica L, In Vitro and In Vivo
    • Authors: Abdnim, R., Ouassou, H., Elrherabi, A., Mekhfi, H., Bnouham, M.
    • Year: 2023
    • Citations: 0
  6. Phenolic Content, Antioxidant, Hemidiaphragm Glucose Consumption, and Hemoglobin Glycosylation Inhibitory Activities of Lavandula stoechas L. Aqueous Extract
    • Authors: Elrherabi, A., Bouhrim, M., Abdnim, R., Legssyer, A., Bnouham, M.
    • Year: 2023
    • Citations: 1
  7. Investigation of in vitro Antioxidant and Hemoglobin Antiglycation Effect of Roasted and Unroasted Argania spinosa L. Seed Oil from Morocco
    • Authors: Daoudi, N.E., Abdnim, R., Elkhadraoui, G., Ziyyat, A., Bnouham, M.
    • Year: 2023
    • Citations: 1
  8. Acute and Subchronic Treatment of Roasted and Unroasted Argan Oil on Postprandial Glycemia and Its Effect on Glucose Uptake by Isolated Rat Hemidiaphragm
    • Authors: Daoudi, N.E., Bouhrim, M., Bouziane, O., Ziyyat, A., Bnouham, M.
    • Year: 2023
    • Citations: 1